HeartSciences (HSCSW) Gains from Investment Securities (2022 - 2026)
HeartSciences (HSCSW) reported Gains from Investment Securities of $467.0 for Q1 2026, down 99.6% on a YoY basis from $117000.0 in Q1 2025, and down 99.92% quarter-over-quarter from $604000.0 in Q4 2025.
HeartSciences (HSCSW) Gains from Investment Securities (2022 - 2026) Analysis & Trends
HeartSciences has reported Gains from Investment Securities for 5 years, with the latest figure at $467.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 99.6% year-over-year to $467.0; the trailing twelve-month figure through Jan 2026 stood at $467.0 (down 99.6% YoY), and the FY2025 full-year result was $173659.0, up 13509.64% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $467.0, down from $604000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.1 million in Q4 2023, with the low at $467.0 in Q1 2026.
- Historically, Gains from Investment Securities has averaged $228283.9 across 5 years, with a median of $117000.0 in 2025.
- Annual changes were most pronounced in 2025 — Gains from Investment Securities soared 10970.38% — and 2026, when it tumbled 99.6%.
- HeartSciences' Gains from Investment Securities stood at $251942.0 in 2022, then surged by 324.05% to $1.1 million in 2023, then sank by 99.49% to $5456.0 in 2024, then soared by 10970.38% to $604000.0 in 2025, then slumped by 99.92% to $467.0 in 2026.
- The last three Gains from Investment Securities figures came in at $467.0 (Q1 2026), $604000.0 (Q4 2025), and $2756.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | HeartSciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 467.00 |
| Jan 31, 2026 | 467.00 |
| Oct 31, 2025 | 604,000.00 |
| Oct 31, 2025 | 604,000.00 |
| Jul 31, 2025 | 2,756.00 |
| Jul 31, 2025 | 2,756.00 |
| Apr 30, 2025 | 173,659.00 |
| Apr 30, 2025 | 173,659.00 |
| Jan 31, 2025 | 117,000.00 |
| Jan 31, 2025 | 117,000.00 |
| Oct 31, 2024 | 5,456.00 |
| Oct 31, 2024 | 5,456.00 |
| Jul 31, 2024 | 52,063.00 |
| Jul 31, 2024 | 52,063.00 |
| Apr 30, 2024 | 74,040.00 |
| Apr 30, 2024 | 74,040.00 |
| Jan 31, 2024 | 150,000.00 |
| Jan 31, 2024 | 150,000.00 |
| Oct 31, 2023 | 1.07 Mn |
| Oct 31, 2023 | 1.07 Mn |